Literature DB >> 25762321

Computational and functional analyses of a small-molecule binding site in ROMK.

Daniel R Swale1, Jonathan H Sheehan2, Sreedatta Banerjee3, Afeef S Husni3, Thuy T Nguyen3, Jens Meiler4, Jerod S Denton5.   

Abstract

The renal outer medullary potassium channel (ROMK, or Kir1.1, encoded by KCNJ1) critically regulates renal tubule electrolyte and water transport and hence blood volume and pressure. The discovery of loss-of-function mutations in KCNJ1 underlying renal salt and water wasting and lower blood pressure has sparked interest in developing new classes of antihypertensive diuretics targeting ROMK. The recent development of nanomolar-affinity small-molecule inhibitors of ROMK creates opportunities for exploring the chemical and physical basis of ligand-channel interactions required for selective ROMK inhibition. We previously reported that the bis-nitro-phenyl ROMK inhibitor VU591 exhibits voltage-dependent knock-off at hyperpolarizing potentials, suggesting that the binding site is located within the ion-conduction pore. In this study, comparative molecular modeling and in silico ligand docking were used to interrogate the full-length ROMK pore for energetically favorable VU591 binding sites. Cluster analysis of 2498 low-energy poses resulting from 9900 Monte Carlo docking trajectories on each of 10 conformationally distinct ROMK comparative homology models identified two putative binding sites in the transmembrane pore that were subsequently tested for a role in VU591-dependent inhibition using site-directed mutagenesis and patch-clamp electrophysiology. Introduction of mutations into the lower site had no effect on the sensitivity of the channel to VU591. In contrast, mutations of Val(168) or Asn(171) in the upper site, which are unique to ROMK within the Kir channel family, led to a dramatic reduction in VU591 sensitivity. This study highlights the utility of computational modeling for defining ligand-ROMK interactions and proposes a mechanism for inhibition of ROMK.
Copyright © 2015 Biophysical Society. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25762321      PMCID: PMC4375722          DOI: 10.1016/j.bpj.2015.01.022

Source DB:  PubMed          Journal:  Biophys J        ISSN: 0006-3495            Impact factor:   4.033


  46 in total

1.  An amino acid triplet in the NH2 terminus of rat ROMK1 determines interaction with SUR2B.

Authors:  K Dong; J Xu; C G Vanoye; R Welch; G G MacGregor; G Giebisch; S C Hebert
Journal:  J Biol Chem       Date:  2001-09-20       Impact factor: 5.157

Review 2.  Sulphonylurea action revisited: the post-cloning era.

Authors:  F M Gribble; F Reimann
Journal:  Diabetologia       Date:  2003-06-18       Impact factor: 10.122

3.  Hyperplasia of the juxtaglomerular complex with hyperaldosteronism and hypokalemic alkalosis. A new syndrome.

Authors:  F C BARTTER; P PRONOVE; J R GILL; R C MACCARDLE
Journal:  Am J Med       Date:  1962-12       Impact factor: 4.965

4.  UCSF Chimera--a visualization system for exploratory research and analysis.

Authors:  Eric F Pettersen; Thomas D Goddard; Conrad C Huang; Gregory S Couch; Daniel M Greenblatt; Elaine C Meng; Thomas E Ferrin
Journal:  J Comput Chem       Date:  2004-10       Impact factor: 3.376

Review 5.  Molecular diversity and regulation of renal potassium channels.

Authors:  Steven C Hebert; Gary Desir; Gerhard Giebisch; Wenhui Wang
Journal:  Physiol Rev       Date:  2005-01       Impact factor: 37.312

6.  Multipass membrane protein structure prediction using Rosetta.

Authors:  Vladimir Yarov-Yarovoy; Jack Schonbrun; David Baker
Journal:  Proteins       Date:  2006-03-01

7.  pH gating of ROMK (K(ir)1.1) channels: control by an Arg-Lys-Arg triad disrupted in antenatal Bartter syndrome.

Authors:  U Schulte; H Hahn; M Konrad; N Jeck; C Derst; K Wild; S Weidemann; J P Ruppersberg; B Fakler; J Ludwig
Journal:  Proc Natl Acad Sci U S A       Date:  1999-12-21       Impact factor: 11.205

8.  Intrinsic sensitivity of Kir1.1 (ROMK) to glibenclamide in the absence of SUR2B. Implications for the identity of the renal ATP-regulated secretory K+ channel.

Authors:  Angelos-Aristeidis Konstas; Michael Dabrowski; Christoph Korbmacher; Stephen J Tucker
Journal:  J Biol Chem       Date:  2002-04-01       Impact factor: 5.157

9.  Rat homolog of sulfonylurea receptor 2B determines glibenclamide sensitivity of ROMK2 in Xenopus laevis oocyte.

Authors:  M Tanemoto; C G Vanoye; K Dong; R Welch; T Abe; S C Hebert; J Z Xu
Journal:  Am J Physiol Renal Physiol       Date:  2000-04

10.  Clinical presentation of genetically defined patients with hypokalemic salt-losing tubulopathies.

Authors:  Melanie Peters; Nikola Jeck; Stephan Reinalter; Andreas Leonhardt; Burkhard Tönshoff; G ünter Klaus G; Martin Konrad; Hannsjörg W Seyberth
Journal:  Am J Med       Date:  2002-02-15       Impact factor: 4.965

View more
  8 in total

Review 1.  Targeting renal epithelial channels for the control of insect vectors.

Authors:  Klaus W Beyenbach; Yasong Yu; Peter M Piermarini; Jerod Denton
Journal:  Tissue Barriers       Date:  2015-09-01

2.  Pore Polarity and Charge Determine Differential Block of Kir1.1 and Kir7.1 Potassium Channels by Small-Molecule Inhibitor VU590.

Authors:  Sujay V Kharade; Jonathan H Sheehan; Eric E Figueroa; Jens Meiler; Jerod S Denton
Journal:  Mol Pharmacol       Date:  2017-06-15       Impact factor: 4.436

3.  ROMK (Kir1.1) pharmacology comes of age.

Authors:  Sujay V Kharade; Daniel R Swale; Jerod S Denton
Journal:  Channels (Austin)       Date:  2015       Impact factor: 2.581

4.  Selective Small Molecule Activators of TREK-2 Channels Stimulate Dorsal Root Ganglion c-Fiber Nociceptor Two-Pore-Domain Potassium Channel Currents and Limit Calcium Influx.

Authors:  Prasanna K Dadi; Nicholas C Vierra; Emily Days; Matthew T Dickerson; Paige N Vinson; C David Weaver; David A Jacobson
Journal:  ACS Chem Neurosci       Date:  2016-11-23       Impact factor: 4.418

5.  ML418: The First Selective, Sub-Micromolar Pore Blocker of Kir7.1 Potassium Channels.

Authors:  Daniel R Swale; Haruto Kurata; Sujay V Kharade; Jonathan Sheehan; Rene Raphemot; Karl R Voigtritter; Eric E Figueroa; Jens Meiler; Anna L Blobaum; Craig W Lindsley; Corey R Hopkins; Jerod S Denton
Journal:  ACS Chem Neurosci       Date:  2016-05-24       Impact factor: 4.418

6.  Discovery and in Vitro Optimization of 3-Sulfamoylbenzamides as ROMK Inhibitors.

Authors:  Matthew F Sammons; Sujay V Kharade; Kevin J Filipski; Markus Boehm; Aaron C Smith; Andre Shavnya; Dilinie P Fernando; Matthew S Dowling; Philip A Carpino; Neil A Castle; Shannon G Zellmer; Brett M Antonio; James R Gosset; Anthony Carlo; Jerod S Denton
Journal:  ACS Med Chem Lett       Date:  2018-01-19       Impact factor: 4.345

Review 7.  Next-generation inward rectifier potassium channel modulators: discovery and molecular pharmacology.

Authors:  C David Weaver; Jerod S Denton
Journal:  Am J Physiol Cell Physiol       Date:  2021-04-07       Impact factor: 5.282

Review 8.  Alternative Targets for Modulators of Mitochondrial Potassium Channels.

Authors:  Antoni Wrzosek; Shur Gałecka; Monika Żochowska; Anna Olszewska; Bogusz Kulawiak
Journal:  Molecules       Date:  2022-01-04       Impact factor: 4.411

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.